ThreadEast
Business trends / The Paper

Fosun Pharma's H1 Revenue Rises 4.75%, Product Prepared for Healthcare Negotiations

View original Chinese title

复星医药上半年营收增4.75%，有产品全力准备医保谈判

Read original on The PaperChinese source · opens in a new tab

The story

An English article summary is not available yet. Read the original on The Paper

Go to the source

Original articles & discussion

For the source’s own discussion, open the original above. No verified comment translations are available here yet.

Ranking history & source details

First recorded Aug 27, 2026, 9:47 PM CST · latest Aug 27, 2026, 9:47 PM CST. Ranks reflect attention on each platform.

Retained daily observations
DayPlatformBest rankLast rank
2026-08-27The Paper#19#19
How rankings are collected

More business trends

The biggest 11.11 event is here: the Double 11 all-platform flash-sale climax is officially underway, with the iPhone 18 Pro Max receiving a 1,600-yuan instant discount on JD.com.Intel Shares Plunge 28.58%, Biggest One-Day Drop in 52 Years; Nearly $150 Billion in Market Value Wiped Out—How Should the Market Reaction Be Interpreted?How Should Vanke’s Loss of 23.94 Billion Yuan from January to September 2026 Be Assessed?Amazon's free cash flow has been “burned through,” Google's profits have fallen, and Intel's revenue outlook fell short of expectations—what can these three things together tell us?